Shares of Tourmaline Oil Corp. TOU advanced 1.44% to C$61.21 Friday, in what proved to be an all-around positive trading ...

Shares of Tourmaline Oil Corp. TOU slipped 0.92% to C$60.34 Thursday, in what proved to be an all-around down trading session ...

Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 – – Tourmaline ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Tourmaline Oil Corp. (TRMLF) reports results for the quarter ended March 2025. While this widely-known consensus ...

Tourmaline Oil stands out as a compelling natural gas investment with strong fundamentals, shareholder returns, and a ...

Nicklaus Children’s Hospital leased at Coral Gables’ Columbus Center, while GummyWorks opened a Palm Beach County facility.

Chardan analyst Daniil Gataulin initiated coverage of Tourmaline Bio (TRML) with a Buy rating and $70 price target The firm cites the ...

For example, biotech and... NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative ...

Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 - - Tourmaline ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Tourmaline Oil Corp. (TRMLF) reports results for the quarter ended March 2025. While this widely-known consensus ...